KOSDAQ-listed company CareLabs announced on the 30th that its subsidiary MediJob Leaders' hospital and medical job recruitment platform, "MediJob," ranked first every week in the Google Play Store app trend index for April.
MediJob has consistently held the top position in the Play Store's medical-related app trend index, which is compiled weekly, throughout April. In the most recent index compiled in the third week of April, MediJob scored 15,578 points, showing more than three times the points difference compared to the second place.
The Play Store medical-related app trend index is calculated by RankeyPie by combining the previous week's keyword search volume and Google Trends scores. RankeyPie utilizes big data technology across various business sectors to analyze trend scores and social media search volume data by portal, releasing the index weekly.
As of the third week of April, MediJob's gender preference was 81% female and 19% male. In terms of age preference, those in their 40s accounted for the highest proportion at 34%, followed by those in their 30s (27%), 20s (20%), and 50s (19%). The gender and age preference proportions showed little change over the three weeks.
A CareLabs representative stated, "Since 'MediJob resume' was included among the detailed related search terms compiled by RankeyPie, MediJob has become an opportunity to reaffirm its status within the domestic medical job recruitment platform industry. Moving forward, we will continue to explore and implement various measures such as incorporating the latest technologies and expanding partnerships with hospitals and clinics to maintain the highest level of recognition in the domestic medical workforce recruitment platform."
The company plans to continue advancing the industry's only 'One-Pass' system, which connects excellent professional medical workforce education and training to employment centered around MediJob, and aims to continuously contribute to the enhancement of social welfare in the future.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

